An Independent Review

Subject Index: Australian Prescriber Volumes 17 to current (1994-2008)

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

To find a reference on this page either scroll or hold down the "Ctrl" key and press "f".

Fabrazyme
  • see agalsidase beta 27(5) 131-3
  • Fabry's disease
  • agalsidase alfa - Replagal (New drug) 27(5) 131-3
  • agalsidase beta - Fabrazyme (New drug) 27(5) 131-3
  • facilitators file
  • combination antihypertensives 24(5) 126
  • thiazides and fractures 24(3) 67
  • factor IX
  • recombinant - haemophilia - Benefix (New drug) 24(3) 71-5
  • factor VIIa
  • recombinant - haemophilia - NovoSeven (New drug) 22(4) 95-8
  • factor VIII
  • inhibitor bypassing fraction - FEIBA-NF - haemophilia (New drug) 30(2) 50-55
  • recombinant - haemophilia A - Recombinate (New drug) 19(1) 24-7
  • famciclovir
  • herpes zoster - Famvir (New drug) 18(3) 58-9
  • famotidine
  • pharmacology 23(3) 57-9
  • Famvir
  • see famciclovir 18(3) 58-9
  • Fanconi's syndrome
  • cysteamine bitartrate - Cystagon (New drug) 20(4) 101-3
  • Fareston
  • see toremifene 21(1) 25-7
  • Faslodex
  • see fulvestrant 30(4) 107-11
  • Fasturtec
  • see rasburicase 26(3) 68-71
  • see rasburicase rys 27(6) 159-65
  • fatty acids
  • omega 3 in hypertriglyceridaemia - PBAC question 19(2) 51
  • feedback
  • prescriber feedback (editorials) 21(1) 2-3
  • FEIBA-NF
  • see factor VIII inhibitor bypassing fraction 30(2) 50-55
  • felodipine
  • clinical pharmacology of calcium channel antagonists 20(1) 5-8
  • new strength - Plendil 17(2) 30-2
  • Femara
  • see letrozole 21(1) 25-7
  • Femoden ED
  • see gestodene ethinyloestradiol combination 18(1) 7-9
  • Femtran
  • see oestradiol 24(1) 20-3
  • fenfluramine
  • in obesity 22(1) 12-6
  • fenofibrate
  • Lipidil - dyslipidaemia (New drug) 27(4) 101-5
  • warfarin interactions 29(6) 166
  • letter 30(2) 32-4
  • fenoldopam
  • dopamine cardiovascular pharmacology 17(2) 42-3
  • fentanyl
  • Durogesic (New formulation) 21(3) 80-3
  • in palliative care 19(3) 66-8
  • fentanyl citrate/ropivacaine hydrochloride combination
  • Naropin with fentanyl (New formulation) 23(4) 84-7
  • Ferriprox
  • see deferiprone 26(3) 68-71
  • ferritin
  • abnormal laboratory results 20(3) 74-6
  • fertility drugs
  • cetrorelix - Cetrotide (New drug) 24(6) 155-8
  • follitropin alpha - recombinant FSH - Gonal-F (New drug) 21(2) 49-55
  • follitropin beta - puregon 23(3) 64-7
  • follitropin beta - recombinant FSH - Puregon (New drug) 19(4) 108-11
  • ganirelix - Orgalutran (New drug) 24(6) 155-8
  • lutropin alfa - Luveris (New drug) 26(6) 146-51
  • fertility testing
  • abnormal laboratory results 25(2) 38-40
  • fever
  • in children - consumer perspective 23(3) 61
  • in children - ibuprofen (letter) 27(3) 55-7
  • and ciprofloxacin (letter) 28(6) 136-9
  • over-the-counter medications and children 24(6) 149-51
  • letter 25(2) 27-8
  • paracetamol in children 23(3) 60-1; 18(2) 33-5
  • letter 23(6) 115-7
  • fexofenadine
  • seasonal allergic rhinitis - Telfast (New drug) 20(2) 45-51
  • letter 20(4) 83-6
  • fibrin sealant
  • surgical haemostasis - Tisseel Duo 500 (New drug) 26(2) 46-7
  • correction 26(4) 95
  • letter 26(4) 75-7
  • fibrinolytic drugs
  • in early management of acute stroke 27(5) 120-3
  • in early management of myocardial infarction 19(2) 52-4
  • in management of coronary disease 24(3) 56-8
  • in management of stroke 22(4) 85-7
  • in post myocardial infarct patients 19(1) 8-10
  • reteplase - myocardial infarction - Rapilysin (New drug) 21(3) 80-3
  • surgery for deep vein thrombosis 21(3) 64-6
  • tenecteplase - myocardial infarction - Metalyse (New drug) 24(2) 43-7
  • Fibro-vein
  • see sodium tetradecyl sulfate 23(6) 137-9
  • filgrastim
  • clinical use 17(4) 95
  • costs and benefits (editorial) 18(2) 26-7
  • finasteride in benign prostatic hypertrophy 18(2) 30-2
  • Proscar (New drug) 17(1) 6-8
  • filgrastim, pegylated
  • pegfilgrastim - neutropenia - Neulasta (New drug) 25(6) 147-51
  • fish
  • management of puncture injuries 30(5) 117-21
  • fish oil
  • NSAIDs in rheumatology (editorial) 29(4) 90-1
  • preparations in hypertriglyceridaemia (PBAC question) 19(2) 51
  • flecainide
  • Flecatab (New brand) 22(6) 147-51
  • Flecatab
  • see flecainide 22(6) 147-51
  • Flixotide
  • see fluticasone 24(4) 100-2; 22(5) 125-7; 19(3) 76-8; 18(1) 7-9; 17(3) 73
  • Flolan
  • see epoprostenol 25(6) 147-51
  • Flomax
  • see tamsulosin hydrochloride 23(3) 64-7
  • flow cytometry
  • abnormal laboratory results 30(5) 128-9
  • Floxsig
  • see flucloxacillin 25(4) 94-9
  • Fluad
  • see influenza vaccine 27(2) 50-1
  • Fluanxol
  • see flupenthixol 17(2) 30-2
  • flucloxacillin
  • Floxsig (New brand) 25(4) 94-9
  • vs other antibiotics in skin and soft tissue infections (editorial) 18(3) 54-6
  • letter 19(1) 3-6
  • fluconazole
  • in cutaneous fungal infections 19(3) 72-5
  • Fludara
  • see fludarabine 18(4) 86-7
  • fludarabine
  • chronic lymphocytic leukaemia - Fludara (New drug) 18(4) 86-7
  • flunitrazepam
  • Rohypnol (New strength) 22(6) 147-51
  • in toothpaste 17(2) 49-51
  • letter 18(1) 4-7
  • fluoroquinolone antibiotics
  • moxifloxacin - Avelox (New drug) 24(6) 155-8
  • fluorouracil
  • colorectal cancer 25(5) 108-10; 25(5) 111-3
  • colorectal cancer - levamisole - Ergamisol (New drug) 20(2) 45-51
  • Onco-Tain (New brand) 22(6) 147-51
  • fluoxetine
  • costs and benefits of antidepressants (editorial) 18(4) 82-4
  • Erotab (New formulation) 22(4) 95-8
  • in human milk (letter) 21(2) 31-4
  • interactions with psychotropic drugs 18(1) 18
  • Lovan (New brand) 23(3) 64-7
  • Lovan (New formulation) 21(4) 108-11
  • review of new antidepressants 18(4) 82-4
  • letters 19(2) 36-8
  • SBPA Fluoxetine (New brand) 23(3) 64-7
  • selective serotonin reuptake inhibitors and suicide risk in children (editorial) 28(5) 111-3
  • letter 29(2) 32-5
  • flupenthixol
  • antipsychotic - Fluanxol (New drug) 17(2) 30-2
  • flurbiprofen
  • mydriatic - Ocufen (New drug) 17(1) 6-8
  • Strepfen (New formulation) 24(2) 43-7
  • flutamide and bicalutamide in prostate cancer
  • PBAC question 22(4) 99
  • fluticasone
  • asthma - Flixotide (New drug) 17(3) 73
  • letter 18(1) 4-7
  • combination inhalers in asthma 28(2) 26-8
  • corticosteroid therapy in asthma 29(3) 63-6
  • Flixotide Junior (New brand) 24(4) 100-2
  • new formulation - Flixotide 22(5) 125-7; 22(4) 95-8; 20(3) 77-9
  • propionate/salmeterol - Seretide Accuhaler (New combination) 23(4) 84-7
  • propionate/salmeterol - Seretide MDI (New formulations) 24(4) 100-2
  • fluvastatin
  • hypercholesterolaemia 22(5) 114-7
  • hypercholesterolaemia - Lescol (New drug) 19(1) 24-7
  • fluvoxamine
  • antidepressant - Luvox (New drug) 20(3) 77-9
  • folate and vitamin B12
  • abnormal laboratory results 22(1) 16-8
  • folinic acid
  • colorectal cancer (PBAC question) 26(4) 77
  • follicle stimulating hormone
  • follitropin alpha - recombinant FSH - Gonal-F (New drug) 21(2) 49-55
  • follitropin beta - recombinant FSH - Puregon (New drug) 19(4) 108-11
  • follitropin alfa
  • Gonal-F (New formulation) 26(5) 118-9
  • Gonal-F (New strength) 25(4) 94-9
  • follitropin beta
  • Puregon (New formulation) 23(3) 64-7
  • fondaparinux
  • thromboembolism prophylaxis - Arixtra (New drug) 25(4) 94-9
  • food
  • antioxidants and nutrition 22(6) 142-4
  • isomaltulose - sugar substitute - warning in fructose metabolism disorders (letter) 31(1) 3-4
  • management of undernutrition 24(5) 113-5
  • meals and medicines 29(2) 40-2
  • nutrition and surgical outcomes 26(6) 136-40
  • foot infections
  • in diabetes 30(1) 21-4
  • Foradile
  • see eformoterol 20(2) 45-51
  • formularies
  • Australian Medicines Handbook (editorial) 20(1) 2-3
  • Australian Medicines Handbook - book reviews 28(4) 93; 28(2) 41; 27(5) 113; 26(5) 110; 24(3) 55; 23(5) 105-6; 22(1) 19
  • Forteo
  • see teriparatide 27(5) 109-13; 27(1) 21-3
  • Fosamax
  • see alendronate 24(4) 100-2; 23(4) 84-7; 19(4) 108-11
  • fosamprenavir
  • Telzir - HIV infection (New drug) 28(1) 19-23
  • fosinopril sodium/hydrochlorothiazide
  • Monoplus (New combination) 23(6) 137-9
  • fosphenytoin
  • epilepsy - Pro-Epanutin (New drug) 23(5) 110-1
  • Fosrenol
  • see lanthanum carbonate 29(2) 53-5
  • framycetin
  • in tear sac obstruction 17(3) 66-8
  • Fraxiparine
  • see nadroparin calcium 22(5) 125-7; 19(2) 38-40
  • Free Trade Agreement
  • US Free Trade Agreement and the drug industry (editorial) 27(3) 54-5
  • letter 27(5) 109-13
  • Freedox
  • see tirilazad mesylate 20(2) 45-51
  • fructose metabolism disorders
  • warning about isomaltulose sugar substitute (letter) 31(1) 3-4
  • frusemide
  • Lasix New strength 24(4) 100-2
  • FSH
  • see follicle stimulating hormone 19(4) 108-11
  • fulvestrant
  • Faslodex - breast cancer (New drug) 30(4) 107-11
  • fungal infections
  • management 19(3) 72-5
  • terbinafine and fungal toenails (letter) 23(4) 72
  • terbinafine and fungal toenails (PBAC question) 22(6) 135
  • posaconazole - Noxafil (New drug) 29(3) 84-7
  • Fuzeon
  • see enfuvirtide - HIV infection 27(6) 159-65
  • Home     Contact Us     Useful Links     Copyright     Privacy     Web Manager